Jules Meijerink was trained in Medical and Biochemical Biology at the University of Nijmegen, and obtained his PhD at this university in 1997 for his study towards “The role of the BCL2 gene family in malignant hematopoiesis and their use for monitoring of disease”

Since September 2016, Jules Meijerink is working as principal investigator in The Princess Máxima Center for Pediatric Oncology in Utrecht, where he will continue his groundbreaking work on T-cell malignancies and therapy resistance mechanisms in children.

During today’s PA meeting, Jules Meijerink alongside our very own Inspire2live Patient Advocate Tjebbe Tauber will present the results of what they have been able to find with data of children with Leukemia through a hackathon. It is amazing what they have been able to achieve in an astonishingly short period of time for the treatment of these children with leukemia. They are trying to bring this to an international level and that is why they are now part of the Global alliance for Genomics and Health. We will learn all about their recent work in what promise to be yet another wonderful and interesting PA meeting.

Source and for more information on Jules Meijerink